Psychiatry is entering a new era. Join host Carlene MacMillan, M.D., Psychiatrist and Chief Medical Officer at Osmind, for Psychiatry Tomorrow, where we delve into captivating conversations with mental health leaders advancing the field. From groundbreaking research and technology, to the modern private practice and the policies shaping psychiatry’s future.
Navigate the exciting realms of neuromodulation, rapid-acting antidepressants, metabolic psychiatry, psychedelic medicine, starting a private practice, and much more.
Join us on this thrilling journey, and let’s transform mental health together.
All content for Psychiatry Tomorrow is the property of Osmind and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Psychiatry is entering a new era. Join host Carlene MacMillan, M.D., Psychiatrist and Chief Medical Officer at Osmind, for Psychiatry Tomorrow, where we delve into captivating conversations with mental health leaders advancing the field. From groundbreaking research and technology, to the modern private practice and the policies shaping psychiatry’s future.
Navigate the exciting realms of neuromodulation, rapid-acting antidepressants, metabolic psychiatry, psychedelic medicine, starting a private practice, and much more.
Join us on this thrilling journey, and let’s transform mental health together.
GLP-1 receptors throughout the brain's reward pathway make these medications psychiatric tools for treating depression and other mental health issues, not just metabolic issues. Learn evidence-based patient selection criteria for treating cravings, compulsivity, and metabolic dysfunction in psychiatric practice with Will Sauvé, MD, and Brittany. Albright, MD, MPH.
Dr. Martha Koo bought her first TMS machine in 2009 when colleagues thought she was "crazy," and now runs 11 centers as immediate past president of the Clinical TMS Society. Her insights reveal why TMS doesn't require patient belief, how early billing accidentally funded research, and where neuromodulation is headed with accelerated protocols and implantable devices.
New research shows exercise (especially when paired with creatine) can match antidepressants for treating mild-to-moderate depression by triggering muscle proteins that act like "miracle grow for the brain." Dr. Nicholas Fabiano explains how psychiatrists are using systematic exercise protocols and creatine supplementation alongside traditional treatments, plus warning signs when exercise becomes harmful. Learn the FIT framework for prescribing exercise and why the future of mental health care means treating mind and body as one system.
After eight years at McLean Hospital's acute unit, Dr. Matt Bernstein chose to treat high-risk psychiatric patients in their communities rather than behind hospital walls. Through his work at Ellenhorn and the innovative Accord Metabolic Psychiatry Program, he demonstrates how combining measurement-based care, metabolic approaches, and meaningful social connection can transform outcomes for complex cases—challenging traditional assumptions about risk and recovery in psychiatry.
Dr. Husseini K. Manji reveals the groundbreaking journey of esketamine (SPRAVATO®) from lab to FDA approval. Discover how this rapid-acting antidepressant is reshaping depression treatment and paving the way for future psychedelic medicines.
Charles Miller, CRNA, shares his journey of building Scenic City Neurotherapy from a small startup to a thriving ketamine and TMS clinic. He offers practical advice on patient education, navigating insurance, and overcoming business challenges, providing invaluable insights for clinicians looking to start or expand their own breakthrough treatment practices.
Explore the complex landscape of MDMA-assisted therapy for PTSD as the FDA's decision looms. Expert panelists discuss key challenges, regulatory hurdles, and the future of psychedelic medicine in mental health treatment.
Dr. David Feifel, M.D., Ph.D., discusses his transition from studying quantum physics to pioneering ketamine and TMS treatments in psychiatry. He shares insights on combining therapies, overcoming institutional barriers, and expanding access to innovative mental health treatments globally. Learn how these approaches are changing outcomes for treatment-resistant patients and shaping the future of psychiatry.
Discover how the ketogenic diet is transforming mental health treatment through the groundbreaking field of metabolic psychiatry. Explore the science behind changing your diet to change your mind. Learn from leading experts Dr. Georgia Ede and Dr. Bret Scher about implementing metabolic psychiatry in clinical practice to improve patient outcomes, even in cases of treatment-resistant illness.
Enhance your understanding of adult ADHD with Dr. Jake Behrens. Learn practical strategies, innovative tools, and expert insights for better patient outcomes, even during the stimulant shortage. Tune into this essential episode of Psychiatry Tomorrow!
Dr. Rebecca Allen, President of the Clinical TMS Society, shares insights from growing her clinic that offers treatments like ECT and TMS, while running COMPASS psilocybin clinical trials. Discover how she uses smart partnerships to grow her practice while expanding access to life-saving treatments.
Learn how to navigate the legal complexities of ketamine therapy in this enlightening episode of Psychiatry Tomorrow. Legal experts Daniel Sternthal and Ethan Minkin offer invaluable strategies to protect your practice, enhance compliance, and ensure patient safety in the evolving landscape of psychedelic medicine.
Discover Dr. Bergina Isbell's innovative approach to mental health, from leveraging ketamine-assisted psychotherapy for neurodiverse individuals to advocating for restorative justice and work-life balance.
Dive into the riveting world of psychiatric clinical trials with Dr. Michael Banov, a triple-board certified expert with over 150 trials under his belt. From the pioneering Clozapine trial to the latest in Vagus Nerve Stimulators, discover the evolution, challenges, and ethical nuances of these groundbreaking studies.
Private practice in psychiatry doesn't mean isolation. Learn how to thrive by leveraging networking, community engagement, and the latest research. This expert discussion offers essential tips for mental health clinicians to stay connected and thrive in private practice.
Set your private mental health practice up for success amidst psychiatry's evolution. Join leading experts Dr. Kristin Budde, Dr. Erick Sheftic, and Dr. Raghu Appasani as they discuss the latest treatments, continuous learning, interdisciplinary collaboration, niching down, and strategies to combat burnout while aligning practice with personal values and patient needs.
Explore the future of Psychiatry. Top Experts discussing the integration of big data, real-world evidence, and breakthrough treatments in personalizing psychiatric care.
Discover General Stephen Xenakis, M.D.'s innovative approach to PTSD treatment, combining his military background with psychiatric expertise. Learn about his advocacy for psychedelic therapies, his leadership in the APPA, and his visions of integrating genetics, AI, and EEG into precision psychiatry.
Stella's acquisition of Field Trip Health unveils a merger blending innovative technology and breakthrough treatments like Stellate Ganglion block and psychedelic-assisted therapies. Dr. Eugene Lipov and Mujeeb Jafferi provide deep insights into the evolving landscape of mental health care, and the challenges and opportunities of running a startup at the frontier of psychiatry.
Psychiatry is entering a new era. Join host Carlene MacMillan, M.D., Psychiatrist and Chief Medical Officer at Osmind, for Psychiatry Tomorrow, where we delve into captivating conversations with mental health leaders advancing the field. From groundbreaking research and technology, to the modern private practice and the policies shaping psychiatry’s future.
Navigate the exciting realms of neuromodulation, rapid-acting antidepressants, metabolic psychiatry, psychedelic medicine, starting a private practice, and much more.
Join us on this thrilling journey, and let’s transform mental health together.
